`
`
`October 17, 2023
`
` Aziz Burgy
`AXINN, VELTROP &
`HARKRIDER LLP
`1901 L Street NW
`Washington, DC 20036
`aburgy@axinn.com
`
`902 Broadway
`18th Floor
`New York, NY 10010-6035
`Erica R. Sutter
`esutter@fenwick.com | 650.335.7626
`
`212.430.2600
`Fenwick.com
`
`
`Stephen R. Auten
`TAFT STETTINIUS &
`HOLLISTER LLP
`111 East Wacker Drive,
`Suite 2800
`Chicago, IL 60601-3713
`sauten@taftlaw.com
`
`Brian Sodikoff
`KATTEN MUCHIN ROSENMAN LLP
`525 West Monroe Street
`Chicago, IL 60661-3693
`brian.sodikoff@katten.com
`
`Michael J. Gaertner
`LOCKE LORD LLP
`111 South Wacker Drive
`Chicago, IL 60606
`mgaertner@lockelord.com
`
`Sharon Lin
`WINSTON & STRAWN LLP
`1901 L Street N.W.
`Washington, DC 20036
`slin@winston.com
`
`Brandon M. White
`PERKINS COIE LLP
`700 13th Street NW, Suite 800
`Washington, DC 20005
`bmwhite@perkinscoie.com
`
`Re:
`
`
`In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 3038; C.A. No. 22-294-
`CFC (Consolidated); C.A. No. 22-1040-CFC (D. Del.)
`
`
`
`Dear Counsel:
`
`Plaintiffs Novo Nordisk Inc. and Novo Nordisk A/S (collectively, “Novo Nordisk”)
`hereby make the following production:
`
`Bates Range
`NN-OZEM-004766890 – NN-OZEM-004775234
`NN-OZEM-004775235 – NN-OZEM-004804104
`
`Production Volume
`NN-OZEM007
`NN-OZEM008
`
`This production is made pursuant to the Protective Order entered in the above actions
`(see C.A. No. 22-cv-294-CFC, D.I. 50; C.A. No. 22-cv-1040-CFC, D.I. 53) and should be
`treated accordingly.
`Any inadvertent production of documents protected from disclosure by the attorney
`client privilege, the work product doctrine, or any other applicable privilege or protection shall
`not be deemed a waiver by Novo Nordisk of any such privilege or protection.
`This production may be accessed via ftp at the address, and using the credentials,
`provided below. The production will be available for download for 7 days. A password to
`access the individual zip files will follow separately. Please let us know if you encounter any
`issues accessing the production.
`
`FTP Address:
`Username:
`Password:
`
`
`
`
`
`
`
`
`
`
`
`Novo Nordisk Exhibit 2019
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00001
`
`
`
`
`
`October 17, 2023
`Page 2
`
`Sincerely,
`
`/s/ Erica R. Sutter
`
`Erica R. Sutter
`
`cc: All Counsel of Record
`